TY - JOUR
T1 - Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis
AU - Berkers, Gitte
AU - van Mourik, Peter
AU - Vonk, Annelotte M.
AU - Kruisselbrink, Evelien
AU - Dekkers, Johanna F.
AU - de Winter-de Groot, Karin M.
AU - Arets, Hubertus G.M.
AU - Marck-van der Wilt, Rozemarijn E.P.
AU - Dijkema, Jasper S.
AU - Vanderschuren, Maaike M.
AU - Houwen, Roderick H.J.
AU - Heijerman, Harry G.M.
AU - van de Graaf, Eduard A.
AU - Elias, Sjoerd G.
AU - Majoor, Christof J.
AU - Koppelman, Gerard H.
AU - Roukema, Jolt
AU - Bakker, Marleen
AU - Janssens, Hettie M.
AU - van der Meer, Renske
AU - Vries, Robert G.J.
AU - Clevers, Hans C.
AU - de Jonge, Hugo R.
AU - Beekman, Jeffrey M.
AU - van der Ent, Cornelis K.
N1 - Publisher Copyright:
© 2019 The Author(s)
PY - 2019/2/12
Y1 - 2019/2/12
N2 - Berkers et al. demonstrate that stem cell cultures (organoids) can be a tool for personalized medicine. They show a high correlation between in vitro and in vivo effects of drugs and demonstrate good-to-excellent predictive values of the organoid test for preclinical identification of responders to CFTR modulators.
AB - Berkers et al. demonstrate that stem cell cultures (organoids) can be a tool for personalized medicine. They show a high correlation between in vitro and in vivo effects of drugs and demonstrate good-to-excellent predictive values of the organoid test for preclinical identification of responders to CFTR modulators.
KW - CFTR
KW - cystic fibrosis
KW - drug response
KW - organoids
KW - personalized treatment
KW - predicting
KW - stem cell cultures
UR - http://www.scopus.com/inward/record.url?scp=85061162213&partnerID=8YFLogxK
U2 - 10.1016/j.celrep.2019.01.068
DO - 10.1016/j.celrep.2019.01.068
M3 - Article
C2 - 30759382
AN - SCOPUS:85061162213
VL - 26
SP - 1701-1708.e3
JO - Cell Reports
JF - Cell Reports
SN - 2211-1247
IS - 7
ER -